Company Info
| Phone: | (617) 349-1971 |
| Year Established: | 2008 |
| Ticker: | CATB |
| Exchange: | NASDAQ |
Contacts
| Primary: | Andrew A. Komjathy CCO |
| Other: | Jill Milne Co-Founder & CEO Noah Clauser CFO Andrea Matthews CBO Chris Morabito, MD CMO |
Company Description
Astria Therapeutics, formerly Catabasis, lead program, STAR-0215, is in preclinical development to treat Hereditary Angioedema, a rare genetic disorder.
